NCT00860808View on ClinicalTrials.gov

Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus

PHASE2CompletedINTERVENTIONAL

Enrollment

248

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

August 31, 2011

Conditions

Tinnitus

Interventions

DRUG

AM-101

Triple intratympanic injection (one on each day 1, 2, and 3)

Trial Locations (1)

89081

Bundeswehrkrankenhaus Ulm, Ulm

Sponsors

Lead Sponsor

Auris Medical AG

All Listed Sponsors

lead

Auris Medical AG

INDUSTRY

NCT00860808 - Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus | Biotech Hunter | Biotech Hunter